Literature DB >> 8896559

Positional cloning of a gene for Hermansky-Pudlak syndrome, a disorder of cytoplasmic organelles.

J Oh1, T Bailin, K Fukai, G H Feng, L Ho, J I Mao, E Frenk, N Tamura, R A Spritz.   

Abstract

Hermansky-Pudlak syndrome (HPS) is an often-fatal autosomal recessive disease in which albinism, bleeding, and lysosomal storage result from defects of diverse cytoplasmic organelles: melanosomes, platelet dense bodies, and lysosomes. HPS is the most common single-gene disorder in Puerto Rico, with an incidence of 1 in 1,800. We have identified the HPS gene by positional cloning, and found homozygous frameshifts in this gene in Puerto Rican, Swiss, Irish and Japanese HPS patients. The HPS polypeptide is a novel transmembrane protein that is likely to be a component of multiple cytoplasmic organelles and that is apparently crucial for their normal development and function. The different clinical phenotypes associated with the different HPS frameshifts we observed suggests that differentially truncated HPS polypeptides may have somewhat different consequences for subcellular function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8896559     DOI: 10.1038/ng1196-300

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  66 in total

Review 1.  Normal and abnormal secretion by haemopoietic cells.

Authors:  J C Stinchcombe; G M Griffiths
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

2.  A case of hermansky-pudlak syndrome with pulmonary sarcoidosis.

Authors:  Lisa Gruson; Thomas Berk
Journal:  J Clin Aesthet Dermatol       Date:  2009-10

3.  The mouse pale ear (ep) mutation is the homologue of human Hermansky-Pudlak syndrome.

Authors:  J M Gardner; S C Wildenberg; N M Keiper; E K Novak; M E Rusiniak; R T Swank; N Puri; J N Finger; N Hagiwara; A L Lehman; T L Gales; M E Bayer; R A King; M H Brilliant
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis.

Authors:  Kevin O'Brien; James Troendle; Bernadette R Gochuico; Thomas C Markello; Jose Salas; Hilda Cardona; Jianhua Yao; Isa Bernardini; Richard Hess; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-03-21       Impact factor: 4.797

5.  Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome.

Authors:  S Hazelwood; V Shotelersuk; S C Wildenberg; D Chen; F Iwata; M I Kaiser-Kupfer; J G White; R A King; W A Gahl
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

Review 6.  Molecular defects that affect platelet dense granules.

Authors:  Meral Gunay-Aygun; Marjan Huizing; William A Gahl
Journal:  Semin Thromb Hemost       Date:  2004-10       Impact factor: 4.180

7.  Predictable and precise template-free CRISPR editing of pathogenic variants.

Authors:  Max W Shen; Mandana Arbab; Jonathan Y Hsu; Daniel Worstell; Sannie J Culbertson; Olga Krabbe; Christopher A Cassa; David R Liu; David K Gifford; Richard I Sherwood
Journal:  Nature       Date:  2018-11-07       Impact factor: 49.962

Review 8.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

Review 9.  Inherited platelet disorders: thrombocytopenias and thrombocytopathies.

Authors:  Giovanna D'Andrea; Massimiliano Chetta; Maurizio Margaglione
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

10.  Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.

Authors:  Yvonne Mica; Gabsang Lee; Stuart M Chambers; Mark J Tomishima; Lorenz Studer
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.